Sugarloaf Wealth Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-300
| Closed | -$12.5K | – | 703 |
|
|
2023
Q2 | $12.5K | Hold |
300
| – | – | ﹤0.01% | 445 |
|
|
2023
Q1 | $18K | Hold |
300
| – | – | ﹤0.01% | 405 |
|
|
2022
Q4 | $22K | Sell |
300
-100
| -25% | -$7.34K | 0.01% | 396 |
|
|
2022
Q3 | $31K | Hold |
400
| – | – | 0.01% | 355 |
|
|
2022
Q2 | $20K | Buy |
400
+100
| +33% | +$5K | 0.01% | 401 |
|
|
2022
Q1 | $25K | Hold |
300
| – | – | 0.01% | 373 |
|
|
2021
Q4 | $23K | Hold |
300
| – | – | 0.01% | 401 |
|
|
2021
Q3 | $35K | Hold |
300
| – | – | 0.01% | 328 |
|
|
2021
Q2 | $67K | Hold |
300
| – | – | 0.02% | 238 |
|
|
2021
Q1 | $40 | Hold |
300
| – | – | 0.01% | 304 |
|
|
2020
Q4 | $52K | Hold |
300
| – | – | 0.02% | 248 |
|
|
2020
Q3 | $33K | Hold |
300
| – | – | 0.01% | 294 |
|
|
2020
Q2 | $18K | Hold |
300
| – | – | 0.01% | 369 |
|
|
2020
Q1 | $20K | Buy |
+300
| New | +$20K | 0.01% | 334 |
|